CareDx, Inc. (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
20.61
+0.15 (0.73%)
Jan 29, 2026, 2:03 PM EST - Market open
CareDx Employees
As of December 31, 2024, CareDx had 650 total employees, including 644 full-time and 6 part-time employees. The number of employees increased by 7 or 1.09% compared to the previous year.
Employees
650
Change (1Y)
7
Growth (1Y)
1.09%
Revenue / Employee
$550,766
Profits / Employee
$108,386
Market Cap
1.06B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 650 | 7 | 1.09% | 644 | 6 |
| Dec 31, 2023 | 643 | -95 | -12.87% | 635 | 8 |
| Dec 31, 2022 | 738 | 93 | 14.42% | 727 | 11 |
| Dec 31, 2021 | 645 | 170 | 35.79% | 633 | 12 |
| Dec 31, 2020 | 475 | 89 | 23.06% | 456 | 19 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| OPKO Health | 2,997 |
| Neogen | 2,974 |
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,200 |
| Fulgent Genetics | 1,313 |
| GeneDx Holdings | 1,000 |
| Twist Bioscience | 979 |
| Veracyte | 824 |
CDNA News
- 1 day ago - CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Business Wire
- 17 days ago - CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 22 days ago - CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - Business Wire
- 4 weeks ago - CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - CareDx Provides Notice of Proposed Derivative Settlement - Business Wire
- 2 months ago - SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation - Business Wire
- 2 months ago - CareDx to Participate in Upcoming Investor Conferences - Business Wire
- 3 months ago - CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 - Business Wire